Consumption of a high calcium mineral water lowers biochemical indices of bone remodeling in postmenopausal women with low calcium intake.
Many postmenopausal women have a calcium intake far below the recommended amount and, in addition to attempting to improve their diet, need a calcium supplement. The aim of the study was to assess the effects of the consumption of a high calcium mineral water (HCaMW) on biochemical indices of bone remodeling in postmenopausal women with low Ca intake. A 6-month randomized double-blind placebo-controlled trial was designed to assess the effects of a daily consumption of 1 liter of a HCaMW (596 mg Ca/l) on serum parathyroid hormone (PTH) and biochemical markers of bone remodeling in postmenopausal women with a dietary Ca intake lower than 700 mg/day. The placebo group drank 1 liter of a mineral water with a low calcium content (10 mg/l). One hundred eighty healthy women were recruited (mean age: 70.1+/-4.0 years); 152 completed the 6-month trial. The changes from baseline of biochemical indices after 6 months consisted of a significant 14.1% decrease of serum PTH, osteocalcin (-8.6%), bone alkaline phosphatase (-11.5%), serum (-16.3%) and urine (-13.0%) type-1 collagen C-telopeptide in the HCaMW group compared to the placebo group, where all biochemical indices increased after 6 months. The additive effect of a small vitamin D supplement (400 iu/day) was also evaluated. In women receiving vitamin D in addition to HCaMW, the decrease in bone indices was not found to be greater than in women drinking only the HCaMW. A daily supplement of 596 mg of Ca through the consumption of 1 l of HCaMW was able to lower serum PTH and the indices of bone turnover in postmenopausal women with a low Ca intake. This could contribute to the repair of calcium deficiency and to the reduction of age-related bone loss in this population.
Meunier
Pierre J
PJ
Faculty of Medicine RTH, Laennec INSERM Unit 403, rue G. Paradin, 69372 Lyon Cedex 08, France. pierre.meunier@sante.univ-lyon1.fr
Jenvrin
Cecile
C
Munoz
Françoise
F
de la Gueronnière
Viviane
V
Garnero
Patrick
P
Menz
Michèle
M
D000368:Aged; D000886:Anthropometry; D015415:Biomarkers / Q000378:metabolism; D016723:Bone Remodeling / Q000187:drug effects*; D002136:Calcium, Dietary / Q000008:administration & dosage* / Q000494:pharmacology; D004311:Double-Blind Method; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008900:Mineral Waters / Q000032:analysis*; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control; D010281:Parathyroid Hormone / Q000031:analogs & derivatives / Q000097:blood; D017698:Postmenopause / Q000502:physiology*; D014807:Vitamin D / Q000008:administration & dosage
D015415:Biomarkers; D002136:Calcium, Dietary; D008900:Mineral Waters; C470125:PTH protein, human; D010281:Parathyroid Hormone; D014807:Vitamin D
Can J Physiol Pharmacol. 1987 Nov;65(11):2202-4
3449184
J Bone Miner Res. 1999 Aug;14(8):1404-10
10457273
Am J Med. 1995 Apr;98 (4):331-5
7709944
Osteoporos Int. 1994 Nov;4(6):323-4
7696826
Osteoporos Int. 2002 Mar;13(3):257-64
11991447
JAMA. 1994 Dec 28;272(24):1942-8
7990248
Clin Sci (Lond). 1996 Sep;91(3):313-8
8869414
Am J Clin Nutr. 2000 Apr;71(4):999-1002
10731509
J Clin Endocrinol Metab. 1995 Nov;80(11):3304-10
7593443
J Bone Miner Res. 1998 Feb;13(2):168-74
9495509
Am J Prev Med. 1991 Nov-Dec;7(6):379-83
1790046
Am J Clin Nutr. 1995 Dec;62(6):1239-44
7491887
Clin Endocrinol (Oxf). 1989 Dec;31(6):667-72
2627757
BMJ. 1994 Apr 23;308(6936):1081-2
8173430
N Engl J Med. 1992 Dec 3;327(23 ):1637-42
1331788
J Bone Miner Res. 1999 Sep;14(9):1614-21
10469291
Br J Nutr. 1996 Jun;75(6):893-903
8774234
Rev Rhum Mal Osteoartic. 1991 Feb;58(2):99-103
2042014
Osteoporos Int. 2000;11(11):938-43
11193246
Osteoporos Int. 1997;7(1):85-6
9102070
Bone Miner. 1986 Oct;1(5):407-13
2849489
N Engl J Med. 1990 Sep 27;323(13):878-83
2203964
J Nutr. 1980 Feb;110(2):212-22
7354392
J Clin Endocrinol Metab. 1996 Mar;81(3):1129-33
8772587